Nonetheless, the combined analyses in liver biopsies from patients with HCC, human hepatoma cell line-derived xenograft model, and cultured human hepatoma cells performed in this study support the benefits of STK25 inhibition in human MASH-driven HCC. This evidence concerns the gene STK25 and hepatocellular carcinoma.